Valens (VLN)vsZepp Health Corp (ZEPP)
VLN
Valens
$2.17
+43.71%
TECHNOLOGY · Cap: $169.52M
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Zepp Health Corp generates 267% more annual revenue ($258.90M vs $70.63M). ZEPP leads profitability with a -15.5% profit margin vs -44.7%. ZEPP earns a higher WallStSmart Score of 41/100 (D).
VLN
Avoid32
out of 100
Grade: F
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+46.9%
Fair Value
$2.90
Current Price
$2.17
$0.73 discount
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Reasonable price relative to book value
16.4% revenue growth
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
0.0% earnings growth
Grey zone — moderate risk
Smaller company, higher risk/reward
ROE of -25.5% — below average capital efficiency
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : VLN
The strongest argument for VLN centers on Debt/Equity, Price/Book, Revenue Growth. Revenue growth of 16.4% demonstrates continued momentum.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : VLN
The primary concerns for VLN are EPS Growth, Altman Z-Score, Market Cap.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
VLN profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor SEMICONDUCTORS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
ZEPP scores higher overall (41/100 vs 32/100) and 43.0% revenue growth. VLN offers better value entry with a 46.9% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Valens
TECHNOLOGY · SEMICONDUCTORS · USA
Valens Technology Inc. (VLN) stands at the forefront of advanced signal processing solutions, specializing in high-speed data transmission for the automotive, consumer electronics, and smart device markets. Leveraging proprietary technologies, the company excels in delivering secure and efficient data transfer, which is crucial for today's data-hungry applications. With a strong emphasis on research and development and strategic partnerships, Valens is well-positioned within the dynamic connectivity landscape, making it an attractive investment opportunity for institutional investors targeting high-growth sectors.
Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SEMICONDUCTORS Stocks
Want to dig deeper into these stocks?